Cognex (CGNX)
NASDAQInformation TechnologyHardware, Equipment & PartsSnapshot 2026-10-29
$58.97+0.92%
Close 2026-10-29 · 1-day change
NASDAQInformation TechnologyHardware, Equipment & PartsSnapshot 2026-10-29
Research Workspace
Put CGNX beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Electronic Equipment & Instruments is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is accelerating — up about 17% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 2% a day.
View RiskHealthy across the board
CGNX's strong recent performance supports owning its growth, despite slowing revenue growth. Q2 FY2026 revenue grew 17% year over year, down from 24% in Q1. Its latest non-GAAP earnings beat consensus by 7.1%. CGNX trades at 42× P/E versus a 30× peer median. Expectations look modest versus our view, though the premium requires continued execution. Our model puts the next-quarter miss probability near 21%. Peer multiples imply a price about 24% below where it trades; our read remains intact. This read is provisional.
Trailing returns as of 2026-10-29. CGNX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 20 analysts currently covering CGNX (as of Oct 2026).
Based on 7 Wall Street analysts offering 12-month price targets for CGNX in the last 4 months.
Continue this research
Compare CGNX with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CGNX Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Electronic Equipment & Instruments — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put CGNX next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Increase revenue growth
Record revenue and margin gains indicate strong growth.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
Current $58.97
The last 12 months of price, then the range of analyst 12-month targets from today’s $58.97.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Increase revenue growth
AI-driven growth aligns with revenue growth objectives.
Advances: Advance AI-enabled machine vision product leadership
Product diversification enhances AI-enabled leadership.
Advances: Expand operating income and margins
Margins expanded significantly, supporting income objectives.
Advances: Expand operating income and margins
Margin expansion aligns with cost objectives.
Advances: Expand adjusted EBITDA margin
Earnings call highlights positive EBITDA trends.
Advances: Increase revenue growth
Above-expected guidance indicates strong demand.
Advances: Increase revenue growth
Above-expected guidance indicates strong demand, boosting revenue growth.